Abstract CT255: ELU-FRα-1: a study to evaluate ELU001 in patients with solid tumors that overexpress folate receptor alpha (FRα)Wen Wee, Eliel Bayever, Yonina R. Murciano‐Goroff et al.|Cancer Research|2023Cited by 7
Phase 1 trial of a novel C’Dot drug conjugate (CDC), ELU001, in patients with solid tumors known to overexpress folate receptor alpha (FRα).Wen Wee, Eliel Bayever, Anthony W. Tolcher et al.|Journal of Clinical Oncology|2023Cited by 7
Study of ELU001, a C’Dot drug conjugate (CDC) targeting folate receptor α (FRα) overexpressing solid tumors.Wen Wee, Eliel Bayever, Catherine W. Reddick et al.|Journal of Clinical Oncology|2024Cited by 3